A carregar...
Tyrosine kinase inhibitors targeting FLT3 in the treatment of acute myeloid leukemia
Acute myeloid leukemia (AML) is a cancer of the myeloid lineage of blood cells. Although significant progress has been made in treating many types of cancers during recent years, AML remains a deadly disease with survival rate lagging behind other blood cancers. A combination of toxic chemotherapies...
Na minha lista:
| Publicado no: | Stem Cell Investig |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AME Publishing Company
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5460107/ https://ncbi.nlm.nih.gov/pubmed/28607922 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/sci.2017.05.04 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|